Home Cart 0 Sign in  

[ CAS No. 10302-78-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 10302-78-0
Chemical Structure| 10302-78-0
Structure of 10302-78-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 10302-78-0 ]

Related Doc. of [ 10302-78-0 ]

Alternatived Products of [ 10302-78-0 ]

Product Details of [ 10302-78-0 ]

CAS No. :10302-78-0 MDL No. :MFCD11113159
Formula : C14H18N4O8 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 370.31 Pubchem ID :-
Synonyms :
2',3',5'-triacetyl-5-Azacytidine
Chemical Name :(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate

Safety of [ 10302-78-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10302-78-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 10302-78-0 ]
  • Downstream synthetic route of [ 10302-78-0 ]

[ 10302-78-0 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 10302-78-0 ]
  • [ 320-67-2 ]
YieldReaction ConditionsOperation in experiment
75% at 20 - 25℃; for 1.58333 h; [00122] The latter was dissolved in MeOH (240 g) and the resulting mixture was filtered (small amount of salt).[00123] 25percent MeONaMeOH (15.4 g; 0.02 mol) dissolved in MeOH (250 g) was added over 5 min.[00124] The resulting mixture is stirred at 20-25°C for 1.5 h. The crystals were filtered and washed with MeOH (300 g).[00125] The wet solid was dried under vacuum at 60°C for 15 h to give 5-azacytidine as an off white solid.[00126] Yield: 75percent, purity >99percent area by HPLC.
400 g With 1,8-diazabicyclo[5.4.0]undec-7-ene In methanol at 20 - 25℃; for 6 h; To a solution of 2,3,5-tri-O-acetyl-β-D-ribofuranose-4-amino-1,3,5-triazine (1.0 Kg) which is dissolved in DBU (5.0 L) was added methanol (40 L) and stirred for 6 h at 20-25 °C. Filtered the solid and washed with methanol (500 mL) and suck dried for 30 min and subjected for drying under vacuum tray drier to get crude 400 g of 4-amino-1-β-D-ribofuranosyl-s-triazin-2(1H)-one.
Reference: [1] Patent: WO2010/17374, 2010, A1, . Location in patent: Page/Page column 18
[2] Patent: WO2010/14883, 2010, A2, . Location in patent: Page/Page column 26
[3] Patent: WO2012/135405, 2012, A1, . Location in patent: Page/Page column 66
[4] Asian Journal of Chemistry, 2018, vol. 30, # 7, p. 1521 - 1524
  • 2
  • [ 52523-35-0 ]
  • [ 13035-61-5 ]
  • [ 10302-78-0 ]
YieldReaction ConditionsOperation in experiment
66.4%
Stage #1: With tin(IV) chloride In dichloromethane at 0 - 5℃; for 6 h; Inert atmosphere
Stage #2: With water; sodium hydrogencarbonate In dichloromethane at 10℃; for 0.5 h;
To silylated 5-azacytosine (Example A-l) was added dichloromethane (1.5 L). The mixture was stirred for 10 minutes under nitrogen atmosphere at 25-30°C to obtain a clear solution. The solution was gradually cooled to 0-5°C. l ,2,3,5-Tetra-0-acetyl-P-D- ribofuranose (255.5 g, 0.8029 mol) was added in one lot at 0-5 °C under nitrogen atmosphere. The mixture was stirred for 10 minutes at 0-5 °C to obtain a clear solution. Stannic chloride (255.6 g, 0.9813 mol) was added drop-wise (addition was slightly exothermic) at < 10°C over a period of 1 hour. The reaction mass was stirred for 5 hours at 0-5 °C under nitrogen atmosphere.[00252] The progress of the reaction was checked by HPLC. 5 g of reaction mass was withdrawn and neutralized with saturated aqueous NaHC03 solution at 10°C. The dichloromethane layer was separated and submitted for IPC-HPLC (In-Process-Control- HPLC). Once IPC had been met (5-azacytosine no more than 0.5percent by HPLC), the reaction mass was transferred to a 5-L round bottom flask for work up.[00253] To the reaction mass was added dichloromethane (1.0 L) and sodium bicarbonate (800.0 g) at < 10°C. Chilled water (1.0 L) was added drop-wise (exothermic) at < 10°C over 30 minutes. The mixture was stirred for 30 minutes at < 10°C. After 15-30 minutes, a white solid (tin oxide) settled at the bottom of the flask. The mixture was filtered through Hyflo.(R)., and washed with dichloromethane (0.5 L). The organic layer was separated at < 10°C, and washed with water (0.75 L) at < 10°C. The organic layer was washed with 10percent EDTA disodium salt solution twice (150.0 g salt, 2 x 750 mL) and water once (1.0 L) at < 10°C. The organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off at 40-45 °C under atmospheric conditions, and further dried at 40-45°C under vacuum (10-15 mmHg) to give a sticky foaming solid. To the residue was added methanol (200.0 mL) at 30-35°C. The solvent was then distilled off at 40-45°C under vacuum (10-15 mmHg), and degassed under vacuum for 30 minutes to afford 2',3',5'-triacetyl-5-azacytidine as a solid (315.0 g, white to off-white crystalline solid). The average output of 2',3',5'-triacetyl-5-azacytidine over multiple runs was about 305.2 g, with an average purity of about 83.7percent>, and an average yield of about 77.2percent (percent> yield takes into account the HPLC purity of the product). Over five runs, the maximum yield of 2', 3 ',5 '-triacetyl-5-azacytidine was about 81.5percent (percent yield takes into account the HPLC purity of the product). Over five runs, the maximum HPLC purity of the product was about 87.8percent>. The reaction conditions for the coupling and the deprotection steps were optimized by varying a number of parameters. The results are summarized in Table 1 below. Inexpensive and commercially readily available metallic Lewis acids, such as stannic chloride and ferric chloride, gave desirable yields for the coupling step.
Reference: [1] Patent: WO2012/135405, 2012, A1, . Location in patent: Page/Page column 64-67
[2] Patent: WO2010/14883, 2010, A2, . Location in patent: Page/Page column 25
  • 3
  • [ 13035-61-5 ]
  • [ 10302-78-0 ]
Reference: [1] Asian Journal of Chemistry, 2018, vol. 30, # 7, p. 1521 - 1524
  • 4
  • [ 40554-98-1 ]
  • [ 52523-35-0 ]
  • [ 10302-78-0 ]
Reference: [1] Patent: WO2010/17374, 2010, A1, . Location in patent: Page/Page column 17-18
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 10302-78-0 ]

Azacitidine Intermediates

Chemical Structure| 931-86-2

[ 931-86-2 ]

6-Amino-1,3,5-triazin-2(1H)-one